Results 191 to 200 of about 500,548 (294)

Safety and effectiveness of the anti‐amyloid monoclonal antibody (mAb) drug lecanemab for early Alzheimer's disease: The pharmacovigilance perspective

open access: yesBritish Journal of Clinical Pharmacology, Volume 91, Issue 5, Page 1352-1360, May 2025.
Abstract The development of humanized IgG1 anti‐amyloid monoclonal antibodies, such as lecanemab, provides a promising novel treatment pathway with potential disease‐modifying effects for patients with early Alzheimer's disease (AD). Lecanemab, which gained marketing approval by the United States Food and Drug Administration (US FDA) in July 2023, has ...
Amy Bobbins   +5 more
wiley   +1 more source

Association of Paternal Diabetes With Hemorrhagic Stroke in Bangladeshi Women: The MAGPIE Study

open access: yesHealth Science Reports, Volume 8, Issue 5, May 2025.
ABSTRACT Background Hemorrhagic stroke (HS) accounts for ~10% of all first‐time strokes, with an increasing incidence in Asia and a scarcity of information available about sex‐related differences. This study investigates the independent predictors of HS among Bangladeshi women.
Md. Abdullah Yusuf   +4 more
wiley   +1 more source

Predicting Intracerebral Hemorrhage Expansion [Letter]. [PDF]

open access: yesNeuropsychiatr Dis Treat
Alvarez A, Rubiano AM, Paiva WS.
europepmc   +1 more source

Clinical and Molecular Features of Patients With Congenital Disorders of Glycosylation in Japan

open access: yesJIMD Reports, Volume 66, Issue 3, May 2025.
ABSTRACT Congenital disorders of glycosylation (CDG) are a heterogeneous group of diseases caused by defects in various steps of the glycosylation pathway. There are over 200 known human glycosylation‐related disorders. Many of these defects lead to multisystemic manifestations, commonly involving the central nervous system, with symptoms ranging from ...
Nobuhiko Okamoto   +2 more
wiley   +1 more source

Unveiling BID: a key biomarker in apoptosis post-intracerebral hemorrhage. [PDF]

open access: yesFront Neurol
Dai K   +7 more
europepmc   +1 more source

Tissue Engineering and Regenerative Medicine: Perspectives and Challenges

open access: yesMedComm, Volume 6, Issue 5, May 2025.
Tissue engineering and regenerative medicine. This review presents cell therapy, extracellular vesicle therapy, and tissue engineering in regenerative medicine, highlighting their key historical milestones, clinical applications, and current challenges.
Van T. Hoang   +12 more
wiley   +1 more source

Predicting 30-Day Outcomes in Primary Intracerebral Hemorrhage Using the Intracerebral Hemorrhage Score: A Study in Bangladesh. [PDF]

open access: yesCureus
Ray SK   +9 more
europepmc   +1 more source

Molecular Hydrogen Therapy: Mechanisms, Delivery Methods, Preventive, and Therapeutic Application

open access: yesMedComm, Volume 6, Issue 5, May 2025.
Molecular hydrogen, delivered through inhalation, hydrogen‐rich water, or hydrogen solution injection, reduces oxidative stress, regulates immune responses, facilitates cell repair, and alleviates inflammatory bowel disease (IBD) and intestinal injury.
Jiayi Jin   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy